Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...

CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...

Dimerix completes patient enrolment in ACTION3 phase 3 trial of DMX-200 to treat focal segmental glomerulosclerosis: Melbourne, Australia Tuesday, December 16, 2025, 18:00 Hrs [IS ...

Amsterdam, the Netherlands Tuesday, December 16, 2025, 17:00 Hrs [IST] ...

US FDA clears Minghui Pharma’s IND application to begin global phase ? trials of MHB018A, a subcutaneous single-domain IGF-1R antibody, in thyroid eye disease: Shanghai Tuesday, ...

Suraksha Diagnostics, in collaboration with Medikabazaar–United Imaging, launches uAcademy to advance radiology education: Our Bureau, Mumbai Tuesday, December 16, 2025, 16:30 H ...

Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD: Melbourne, Australia Tuesday, December 16, 2025, 14:00 ...

Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs: Our Bureau, Bengaluru Tuesday, December 16, 2025, 16:45 Hrs [IST] Senores Pharmaceuticals has entered into a defini ...

Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor: Hong Kong Tuesday, December 16, 2025, 14:3 ...

Gujarat Kidney and Super Speciality, a regional healthcare company located in Gujarat, announced that its initial public offering (IPO) for subscription from Monday, 22nd December, 2025, and closes on ...

Global pharma major Lupin Limited (Lupin) announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). These ...

Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis: Washington Tuesday, December 16, 2025, 15:00 Hrs [IST] Vanda Pharmaceuticals Inc., (Van ...